SPDR S&P Biotech ETF
129 hedge funds and large institutions have $1.68B invested in SPDR S&P Biotech ETF in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 55 reducing their positions, and 8 closing their positions.
Holders
129
Holders Change
+6
Holders Change %
+4.88%
% of All Funds
3.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
15
Increased
35
Reduced
55
Closed
8
Calls
$51.9M
Puts
$90M
Net Calls
-$38.1M
Net Calls Change
+$179K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$527M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$351M |
| 3 |
CCMH
3
Cornerstone Capital Management Holdings
New York
|
$6.04M |
| 4 |
U
4
UBS
Zurich,
Switzerland
|
$75.7M |
| 5 |
LCS
5
Levin Capital Strategies
New York
|
$2.87M |
Top Sellers
| 1 |
1
Citigroup
New York
|
$56.5M |
| 2 |
SCM
2
Sandler Capital Management
New York
|
$9.16M |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$51.5M |
| 4 |
TH
4
Timber Hill
Greenwich,
Connecticut
|
$3.21M |
| 5 |
5
Jane Street
New York
|
$316K |
